Avner Lushi
Director · Silexion Therapeutics Corp
Individual
- 2026
- Feb 23, 2026
- 1
Filings (90d)
0
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Avner Lushi files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mitchell Shirvan - $31K in SLXN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Avner Lushi?
Avner Lushi is a corporate insider, tracked as Director of Silexion Therapeutics Corp (SLXN). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Avner Lushi last file a Form 4?
The only primary Form 4 on record is dated 23 February 2026.
